Coronary Bypass Devices LLC
Conduct trials to show a new medical device solves problem that prevents existing devices from capturing more than 8% of $1 billion market.
CBD has ties to the Miami Medical Community for conducting trials of a new medical device that avoids a step devices sold by Medtronic and J&J often fail. With this failure rate sales are limited to 50,000 out of 700,000 cases in a niche created by chronic total occlusions which can't be treated by normal balloons so are primarily treated by surgery. A device trials show avoids the failure problem will replace surgery to fill $1 billion niche.